Document is current
Any future updates will be listed below
-
Authors
Mittal, Nidhi
Kumar, Sahil
Rajmani, Raju S.
Singh, Randhir https://orcid.org/0000-0001-7388-225X
Lemoine, Céline
Jakob, Virginie
BJ, Sowrabha
Jagannath, Nayana https://orcid.org/0000-0003-2064-667X
Bhat, Madhuraj
Chakraborty, Debajyoti https://orcid.org/0000-0002-1254-6313
Pandey, Suman
Jory, Aurélie
SA, Suba Soundarya https://orcid.org/0000-0002-2188-5579
Kleanthous, Harry https://orcid.org/0000-0001-7115-235X
Dubois, Patrice
Ringe, Rajesh P.
Varadarajan, Raghavan
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-005948)
- License Information
-
More Information
Article History
Received: 16 April 2023
Accepted: 2 October 2023
First Online: 25 October 2023
Competing interests
: A provisional patent application has been filed for the RS2 formulations described in this manuscript. R.V., N.M., and R.S. are inventors. R.V. is a co-founder of Mynvax, R.S., S.B.J., N.J., M.B., and S.P. are employees of Mynvax Private Limited. Other authors declare that they have no competing interests.
